470 results about "Cell culture" patented technology

The invention belongs to the technical field of cosmetics, and discloses a wrinkle-removing and anti-aging composition containing recombinant collagen as well as a preparation method and application of the wrinkle-removing and anti-aging composition. The composition is prepared from the following components: 20.4 to 35.6 percent of glycerol, 1.1 to 3.5 percent of 1, 2-hexanediol, 8.2 to 15.4 percent of apple fruit cell culture extract, 1.6 to 3.2 percent of inositol, 0.2 to 1.0 percent of elastin, 0.1 to 1.7 percent of hydroxyproline, 0.1 to 1.0 percent of sodium polyglutamate, 0.1 to 1.0 percent of sodium hyaluronate, 0.01 to 0.1 percent of acetyl hexapeptide-8, 0.01 to 0.1 percent of fibronectin, 1.72 to 3.21 percent of soluble collagen and the balance of deionized water. The amino acid sequence of the soluble collagen is as shown in SEQ ID NO. 1. The skin care product prepared by adding the anti-wrinkle and anti-aging composition is good in safety and has the effects of resisting wrinkles, improving skin elasticity and resisting aging.

This invention discloses a monoclonal antibody against human hepatitis B e antigen and its application, relating to the field of hepatitis B detection technology. In the heavy chain variable region of the monoclonal antibody, the amino acid sequences of the complementarity-determining regions (CDR1-3) are as shown in SEQ ID NO. 1-3 or have at least 95% homology with the sequences shown in SEQ ID NO. 1-3; in the light chain variable region, the amino acid sequences of the complementarity-determining regions (CDR1 and CDR3) are as shown in SEQ ID NO. 4 and 5 or have at least 95% homology with the sequences shown in SEQ ID NO. 4 and 5, and the amino acid sequence of the complementarity-determining region (CDR2) is FAS. The monoclonal antibody provided by this invention can effectively recognize natural hepatitis B e antigen, and the titer of the supernatant from B cell culture can reach 1:10000, making it fully applicable to the detection and research of human hepatitis B e antigen. The chemiluminescent reagent prepared using the monoclonal antibody described in this invention has advantages such as high specificity, strong anti-interference ability, high detection sensitivity, and good stability, with almost no missed detections, and can replace imported reagents.

The invention relates to the technical field of synthetic biology, metabolic engineering and cell culture. The present invention provides a cell for the production of a negatively charged, preferably sialylated, oligosaccharide wherein the cell is genetically engineered to have or express, preferably overexpress, a hydrolytic UDP-N-acetyl-D-glucosamine-2-epimerase. The invention further provides the use of said cells in culture or incubation. Also described are methods of producing negatively charged, preferably sialylated oligosaccharides using the cells, and purification of the negatively charged, preferably sialylated oligosaccharides.

A method for constructing a microfluidic bone organoid-on-chip can continuously observe the impacts of different external factors on a bone tissue structure based on the “ternary regulation theory” of bone angiogenesis-bone resorption-osteogenesis coupling. The method includes: (1) building a visual three-dimensional cell cultivation platform to continuously observe impacts of different external factors on a ternary regulation theory based on angiogenesis of osteoclast precursors, osteoblasts and osteoclasts, such that a user is allowed to directly observe interactions among various kinds of cells; (2) designing microfluidic channels in a chip to allow a reagent involved to present a concentration gradient distribution in the chip; and (3) adding three bioinks including osteoblasts, osteoclasts and vascular endothelial cells respectively, so as to reflect the three cell components individually, in pairs, and as a whole in the chip. An apparatus for constructing a microfluidic bone organoid-on-chip is further provided.

The invention discloses a method for preparing human metapneumovirus nucleocapsid protein based on an insect-baculovirus system. Comprising the following steps: 1) constructing a recombinant vector with a human metapneumovirus nucleocapsid protein coding sequence: sequentially connecting a sequence for promoting secretory expression, the human metapneumovirus nucleocapsid protein coding sequence and a tag sequence from 5'to 3 'ends in the recombinant vector; 2) converting the recombinant vector with the human metapneumovirus nucleocapsid protein coding sequence constructed in the step 1) into a competent cell containing a baculovirus genome plasmid Bacmid to obtain a recombinant baculovirus genome plasmid; and 3) transfecting insect cells with the recombinant baculovirus genome plasmid obtained in the step 2), culturing and purifying to obtain the human metapneumovirus nucleocapsid protein. The invention provides the preparation method of the human metapneumovirus nucleocapsid protein, and a material support is provided for subsequent further research.

The present invention relates to a cell biomass (e.g. food product or pet food product) or its components prepared from cultivated metazoan cells, method of its preparation and a system for its preparation.

The invention provides bovine ephemeral fever virus positive serum as well as a preparation method and application thereof. The preparation method comprises the following steps: culturing bovine ephemeral fever virus by using MDBK suspension cells, inactivating by using beta-propiolactone, concentrating by using a 500kd hollow fiber column to obtain an antigen solution, and emulsifying the antigen solution and 61VG adjuvant according to a mass ratio of 1: 1.5 to prepare the vaccine; carrying out primary immunization and secondary immunization on the receptor, collecting blood of which the serum neutralizing antibody titer is greater than 1: 4096 14-21 days after the secondary immunization, and separating to obtain positive serum. The positive serum can be used for specific test, identification test and the like of the bovine ephemeral fever virus, can also be used for preparing related reagents, kits and standard substances, and provides efficient and normative technical support for prevention and control of bovine ephemeral fever.

The invention provides a method for obtaining a broadly neutralizing antibody (bNab), including screening memory B cell cultures from a donor PBMC sample for neutralization activity against a plurality of HIV-1 species, cloning a memory B cell that exhibits broad neutralization activity; and rescuing a monoclonal antibody from that memory B cell culture. The resultant monoclonal antibodies may be characterized by their ability to selectively bind epitopes from the Env proteins in native or monomeric form, as well as to inhibit infection of HIV-1 species from a plurality of clades. Compositions containing human monoclonal anti-HIV antibodies used for prophylaxis, diagnosis and treatment of HIV infection are provided. Methods for generating such antibodies by immunization using epitopes from conserved regions within the variable loops of gp120 are provided. Immunogens for generating anti-HIV1 bNAbs are also provided. Furthermore, methods for vaccination using suitable epitopes are provided.

The invention provides 3D tumor cell culture hydrogel as well as a preparation method and application thereof. The 3D tumor cell culture hydrogel is prepared from the following raw materials: polyvinylpyrrolidone and polyvinyl alcohol. The preparation method comprises the following steps: mixing a polyvinylpyrrolidone solution with a polyvinyl alcohol solution, adjusting the pH value, and freezing-unfreezing to obtain the 3D tumor cell culture hydrogel. The 3D tumor cell culture hydrogel provided by the invention does not need to be additionally added with a chemical cross-linking agent, and the material is high in biocompatibility and flexible in modulus adjustment, and can be well applied to a 3D in-vitro culture model of tumor cells.

The invention provides a culture method of avian encephalomyelitis virus, and belongs to the technical field of biology. According to the method, chicken lymphoma suspension cells are adopted to culture the avian encephalomyelitis virus, the titer of the obtained avian encephalomyelitis virus reaches 106.5-6.8 EID50 / 0.2 mL, and the method is short in culture period, high in production efficiency, low in cost, controllable in quality and capable of being used for large-scale industrial production.

The utility model discloses a bioreactor bubble-free air interchanger which comprises a shell, an air inlet pipe extends into the shell, an air outlet port of the air inlet pipe extends into the shell, the top of the shell is connected with an exhaust pipe, an air inlet port of the exhaust pipe is located at the top of the shell, a liquid passing hole is formed in the cylinder wall of the shell, and the liquid passing hole is communicated with the air inlet port of the air inlet pipe. A filtering body for liquid to pass through is arranged on the periphery of the shell and is of a porous net structure. Compared with the prior art, the bubble-free air interchanger of the bioreactor has the advantages that the bubble-free air interchanger of the bioreactor is made of 316 stainless steel materials, is small in occupied space and easy to install and operate, can achieve bubble-free air interchange in the bioreactor, eliminates bubble damage to cells while meeting the requirement of a culture system for oxygen concentration, and improves the air interchange efficiency of the bioreactor. The device is suitable for the culture process of mammalian cells sensitive to shear force. The device is flexible in application, can be adapted to bioreactors of different specifications, and is easy for process development and amplification.

The invention discloses a sleep-promoting nasal spray based on mesenchymal stem cell-derived exosomes and preparation and application thereof.The preparation method comprises the steps that 1, mesenchymal stem cells separated from umbilical cord tissue are cultured to P3-P5 generations, cell culture supernate is collected, cells are digested, and then cell debris and macromolecular impure protein are removed through pretreatment; (2) filtering and concentrating the pretreated cell culture supernatant and replacing a part of solution; (3) carrying out degerming filtration on the solution obtained in the step (2) through a 0.22 [mu] m filter membrane to obtain an MSC-Exos solution; and (4) adding a stabilizer with a proper concentration into the MSC-Exos solution to obtain a compound MSC-Exos solution, namely the sleep-promoting nasal spray. The product is a cell-derived natural active substance, can significantly improve sleep, and does not involve any pharmaceutical ingredient.

The invention discloses a preparation method of a cochlear organ chip integrated with a blood labyrinth barrier, and belongs to the field of biomedical engineering. The preparation method of the simulated blood labyrinth barrier comprises the following steps: constructing an endothelial cell culture cavity and a pericyte culture cavity, and separating the endothelial cell culture cavity and the pericyte culture cavity through a simulated basement membrane; and respectively inoculating percutaneous cells and endothelial cells into a percutaneous cell culture cavity and an endothelial cell culture cavity, and culturing to obtain the simulated blood lost barrier. The chip can effectively simulate the structure and the function of the BLB, and the barrier integrity of the BLB is evaluated through TEER (trans-epithelial electrical resistance) measurement and an apparent permeability coefficient. The invention also relates to application of the chip in NIHL drug screening, in particular to drug evaluation for oxidative stress induced inner ear organ injury. Through the platform, the protection effect of the candidate drugs on the TBHP-induced oxidative stress injury of the inner ear organs can be evaluated, and a new tool and thought are provided for developing novel NIHL treatment drugs.

The invention discloses a bioreactor multi-parameter adaptive control system and method based on machine learning, and belongs to the technical field of bioreactor intelligent control, and the bioreactor multi-parameter adaptive control system comprises a bioreactor hepatocyte culture unit, a data acquisition and control unit and a machine learning intelligent decision-making unit. And the data acquisition and control lower computer controls operation variables such as gas supply, sampling and perfusion in the culture unit execution mechanism, collects culture process data returned by the parameter detection module, constructs a data-driven cell state prediction model by utilizing machine learning, and optimizes model parameters and operation variables based on a prediction result to realize closed-loop control. The method can overcome the defect that there is no precise mechanism model for hepatic cell culture, and multi-parameter collaborative optimization can be realized only depending on process data, so that the state of the hepatic cells is sensed in real time, full-cycle optimization of cell viability and functions is realized, and the activity and density of hepatic cell culture are effectively improved.

The disclosure relates to growing cells, directing cells to grow into specified cell types, genetically and physically manipulating cells, and addressing one or more individual cells within a mixed cell population. Aspects of the disclosure relate to vectors useful to induce developmental changes in cells, in which those vectors have a temporal component. Vectors of the disclosure encode a controllable, temporal series of events. Once the vectors are delivered into target cells, a series of discrete and different genetic events may be induced. The disclosed methods generally provide for the temporal encoding of multiplex genetic effectors in vector format for cell state transitions.

The invention discloses a culture method for improving proliferation and differentiation capacity of NK (Natural Killer) cells based on angelica sinensis-astragalus membranaceus exosomes, which comprises the following steps: firstly extracting exosomes in angelica sinensis and astragalus membranaceus, then adding the exosomes into an NK cell culture system according to a specific concentration, and regulating and controlling an NK cell signal channel by virtue of active ingredients carried by the exosomes so as to improve the proliferation and differentiation capacity of the NK cells. Therefore, the proliferation rate and differentiation maturity of the NK cells are remarkably improved. Experimental results show that compared with a traditional culture method, the proliferation multiple of the NK cells cultured through the method is increased by 28.99%-33.69%, the proportion of differentiated mature cells is increased by 15.91%-28.30%, and the cell killing activity is not remarkably reduced. The method can be widely applied to the field of immune cell treatment, provides a high-quality NK cell source for clinic, effectively solves the problems of slow cell proliferation rate, low differentiation maturity, easy activity reduction after large-scale culture and the like in traditional NK cell in-vitro culture, and has important clinical application value and industrialization prospect.

The present invention belongs to the field of treatment of ulcerative colitis and provides an application of extracellular vesicles derived from Herba Euphorbiae in preparing a drug for preventing and treating ulcerative colitis. The application includes extraction and preparation of extracellular vesicles derived from Herba Euphorbiae and research on the preventive and therapeutic effects of extracellular vesicles derived from Herba Euphorbiae on ulcerative colitis in mice. The specific steps are as follows: Step 1, extracting leaf cells from Herba Euphorbiae: selecting fresh and healthy Herba Euphorbiae leaves as experimental materials and chopping them into pieces, adding the chopped samples into an enzymatic hydrolysis solution, ensuring that the samples are fully in contact with the enzymatic hydrolysis solution and incubating them, gently turning or stirring during the incubation to promote the enzymatic hydrolysis process, thereby isolating the leaf cells; Step 2, culturing the leaf cells of Herba Euphorbiae: culturing the leaf cells of Herba Euphorbiae in a culture medium; The present invention confirms that extracellular vesicles derived from Herba Euphorbiae can be used to treat ulcerative colitis, provides an experimental basis for the development of new drugs for the clinical prevention and treatment of IBD, and has good application prospects.

The invention relates to the technical field of bioengineering and digital twinning, and discloses a digital twinning modeling regulation and control system for a stem cell culture process, which comprises a signal acquisition module, a space-time coding module, a dynamic modeling module, a regulation and control decision module, a closed-loop execution module and an interactive interface module, according to the method, multi-modal data is collected through a composite sensor and coded into a space-time tensor, a gene noise-metabolic force field cross-scale dynamic model is constructed, a microenvironment regulation and control instruction is generated in combination with a multi-agent game, closed-loop cooperative regulation and control of a biochemical gradient field and mechanical parameters are achieved, and dynamic interactive calibration is achieved through a three-dimensional thermodynamic diagram. According to the method, a stem cell differentiation cross-scale dynamic model is constructed through multi-modal data fusion, microenvironment closed-loop regulation and control are realized by using space-time tensor coding and a multi-agent game strategy, and prediction precision and regulation and control real-time performance of a digital twin system are improved in combination with a three-dimensional visual interaction platform.

The invention belongs to the technical field of organ chips, provides an in-vitro brain lymphatic system chip construction method and a brain lymphatic system chip, and makes up the blank of brain lymphatic system in-vitro model construction. The method comprises the following steps: firstly, carrying out flushing treatment, disinfection and sterilization treatment, rinsing treatment and cell culture on a micro-fluidic channel in the chip; then, in the treated micro-fluidic channel, blood vessel channel cell inoculation and brain parenchyma channel cell inoculation are carried out; and finally, in the blood vessel channel, perfusion is carried out once at a preset flow speed every preset duration, shear force stimulation simulating pulse type blood flow is provided, basic formation of in-vitro cerebral vessels is achieved after continuous perfusion, perfusion is carried out once at a preset flow speed every preset duration, shear force stimulation simulating pulse type blood flow is provided, and in-vitro cerebral vessels are formed. Intermittent liquid flow simulating arterial fluctuation is achieved.

The invention relates to the technical field of data processing of stem cell culture equipment, and discloses a data processing system of stem cell culture equipment, which comprises the following modules: a data acquisition module generates a state and a control sequence by acquiring parameters in a stem cell culture process; the state modeling module constructs a multi-dimensional state matrix and a control matrix based on the collected data; the trend prediction module is used for constructing a state transition model and generating a prediction state vector at the next moment; the optimization control module solves a control strategy vector based on the prediction state vector; the control execution module is used for converting the control strategy vector into an actual control instruction; the closed-loop feedback module collects the actual state after adjustment and is used for correcting the state and the control matrix and dynamically updating the state transition model. According to the method, the state matrix and the control matrix based on the sliding time window are constructed, so that multi-dimensional time sequence information in the stem cell culture process is subjected to structured expression, and the effect of capturing the dynamic change trend of the environment in real time is achieved.

A cell detachment apparatus that detaches cells placed on a culture surface of a culture container for cells by applying vibration to the cells includes a vibrator and a vibrating plate, wherein the vibrator, the vibrating plate, an acoustic transmission medium, and the culture container are stacked in this order, wherein a bending vibration is excited on the culture container when a vibration of the vibrating plate is transmitted to the culture container via the acoustic transmission medium, and wherein the acoustic transmission medium and the culture container come into contact with each other at a region including an antinode of the bending vibration and do not come into contact at a node of the bending vibration.

The invention provides a gamma delta T cell culture method and a culture medium, and belongs to the technical field of T cell culture. Modified nanoparticles, zoledronic acid, vitamin C and glutamine are added into a 1640 culture solution, the concentration of the modified nanoparticles ranges from 0.5 g / L to 1 g / L, the concentration of the zoledronic acid ranges from 0.5 mu mol / L to 1.5 mu mol / L, the concentration of the vitamin C ranges from 200 mu mol / L to 500 mu mol / L, and the concentration of the glutamine ranges from 0.1 mmol / L to 0.2 mmol / L. The prepared culture medium can efficiently stimulate amplification of the gamma delta T cells and improve the killing activity of the gamma delta T cells, meanwhile, the survival rate of the gamma delta T cells is also improved, and meanwhile, the culture method of the gamma delta T cells is simple, low in cost and wide in application prospect.

The invention relates to the technical field of biomedical detection, in particular to an exosome particle size distribution detection processing method and system which are used for accurately measuring and analyzing the size distribution characteristics of exosomes in a biological sample. The method comprises the following steps: firstly, extracting and marking an exosome from a cell culture supernatant by using an exosome extraction kit; arranging a capture probe in a light scattering detection system, wherein the system comprises a microscope lens and a three-color camera which are connected with a calculation module; an exosome image is transmitted to a three-color camera through a microscope lens, and detection is carried out by utilizing the fluorescence wavelength and a light scattering signal of a super-continuous laser; in the continuous change of the laser emission angle, calculating the particle size distribution of the exosome according to an optical signal; according to the method, the detection precision and accuracy are improved, the improvement from two-dimensional information to three-dimensional information is realized, the characterization problem of the non-spherical exosome is solved, and a more accurate and comprehensive tool is provided for exosome research.

The invention provides a pharmaceutical composition for treating non-small cell lung cancer and application of the pharmaceutical composition. The pharmaceutical composition comprises gefitinib, erlotinib, afatinib, neratinib, osimertinib and the like which serve as active ingredients. The pharmaceutical composition disclosed by the invention can simultaneously contain various EGFR inhibitors as active ingredients, and the active ingredients are controlled at ultra-low dosage, so that the pharmaceutical composition not only can ensure the treatment effect, even the drug effect of the pharmaceutical composition is obviously superior to that of a high-dosage EGFR inhibitor independent administration group, but also can ensure the safety, and the pharmaceutical composition is suitable for clinical application. And after the active components are combined, a good synergistic effect is achieved, and more importantly, the occurrence of drug resistance can be remarkably reduced or even resisted. In a lung cancer cell culture experiment, the EGFR inhibitor independent administration group has a drug resistance phenomenon at the earliest 20 days, but the pharmaceutical composition group still has no drug resistance phenomenon after 160 days of administration.

The invention relates to the technical field of biological materials, in particular to a biocompatible method for synthesizing quantum dots from living cells, which comprises the following steps: in the living cell culture process, adding an organic selenium compound containing Se-Se or Se-S bonds into a culture medium, and incubating to obtain selenized cells; further culturing by using a culture medium containing a metal ion-glutathione complex to obtain quantum dots containing metal elements and Se elements; according to the method, the generation of an active selenium precursor with cytotoxicity, such as hydrogen selenide, is effectively avoided, and meanwhile, the outbreak of active oxygen species in cells is also avoided, so that high quantum dot synthesis efficiency is shown. In-vitro cell experiment results show that the cells are endowed with a fluorescent function and still maintain good cell viability, and the cell viability is maintained at 80% or above; in-vivo experiment results show that the fluorescent cells with the synthesized quantum dots have good proliferation, tumor formation, invasion and metastasis capabilities in vivo.

The invention discloses a filtering and sorting device for biological cell culture and a use method of the filtering and sorting device, and belongs to the technical field of biological cell culture.The filtering and sorting device is provided with a first arc-shaped connecting block, a sealing ring, an arc-shaped connecting clamping plate, a clamping spring, a fixing clamping column, a guide cylinder and a top cover, and the arc-shaped connecting clamping plate is tightly attached to the surface of the sealing ring; meanwhile, a push plate is pushed to drive a fixed clamping column to move, so that a clamping spring is extruded and deformed on the surface of a mounting column, after an arc-shaped connecting clamping plate is tightly attached to the surface of the sealing ring, the fixed clamping column corresponds to clamping grooves in the two sides of an I-shaped clamping block in position, and the push plate is loosened to jack up the fixed clamping column to be clamped into the clamping grooves in the two sides of the I-shaped clamping block under the rebound effect of the clamping spring; and therefore, the concave mounting blocks are clamped and fixed to the two sides of the I-shaped clamping blocks, the arc-shaped connecting clamping plates are tightly attached and fixed to the surface of the sealing ring to connect and fix the collecting barrel and the top cover, and therefore the collecting barrel, the sealing ring and the top cover can be conveniently connected and fixed or detached and cleaned, and the flow guide barrel can be detached and replaced.

The invention provides a stem cell culture process information abnormity early warning method, which comprises the following steps: preprocessing original data in a stem cell culture process, extracting layered features to obtain basic statistical features, time sequence trend features and environmental factor interaction features, and updating the features in real time through a dynamic sliding window, after the verified feature set is obtained, fusion calculation is carried out to obtain a multi-dimensional fusion feature set; calculating a trend deviation degree, a feature correlation degree and a fluctuation dispersion degree of the multi-dimensional fusion feature set, and carrying out dynamic weight distribution and fusion to obtain a fusion anomaly degree value; and matching the fusion anomaly degree value with a multi-level threshold value to obtain a matching result, judging an abnormal state type in combination with an association relationship between the feature anomaly type and the cultivation stage, and generating an anomaly early warning result. According to the method, through data preprocessing, layered feature extraction and fusion and dynamic anomaly calculation, the accuracy, real-time performance and practicability of stem cell culture anomaly early warning are improved.

The invention discloses a skin-tightening anti-wrinkle essence and a preparation process thereof, and relates to the technical field of cosmetic preparation, and the preparation process comprises the following steps: obtaining animal umbilical cord tissue, culturing, collecting cell culture supernatant after culture, carrying out low-speed centrifugation to remove cells and dead cells, and carrying out concentration, filtration and sterilization through a tangential flow membrane technology to obtain the skin-tightening anti-wrinkle essence. The animal umbilical cord extract is obtained; the preparation method comprises the following steps: mixing the animal umbilical cord extract with water, butanediol, glycerol, hydroxypropyl tetrahydropyrantriol, 1, 2-hexanediol, trehalose, p-hydroxyacetophenone, allantoin, hydrolyzed sodium hyaluronate, sodium hyaluronate, tetrahydromethylpyrimidine carboxylic acid, xanthan gum and essence, homogenizing under a stirring condition, and standing for defoaming. By constructing an active stable microenvironment and an efficient transdermal delivery system, the technical problem that the animal umbilical cord extract serving as a core component is easy to inactivate and difficult to absorb is solved, and a faster and more stable skin structure remodeling effect is realized by utilizing the synergistic effect of the animal umbilical cord extract and functional components.

The invention provides a lung stem cell peptide for treating pulmonary nodule as well as a preparation method and application thereof, and belongs to the technical field of biological pharmacy. The method comprises the following steps: performing induced differentiation on iPSC to obtain lung stem cells; lung stem cells are cultured and centrifuged, supernatant is collected, and a lung stem cell crude solution is obtained; mixing the lung stem cell crude liquid with protease, performing enzymolysis, centrifuging, concentrating, and performing spray drying to obtain the lung stem cell peptide for treating pulmonary nodule. By optimizing the composition of each culture medium, the iPSC is induced and differentiated into the lung stem cells, then the lung stem cell peptide is extracted and separated from the lung stem cells, and the extracted lung stem cell peptide migrates to the lung in a vein reinfusion mode, so that the generation of lung tumor nodules can be effectively inhibited, the number of the lung tumor nodules is greatly reduced, and the lung tumor nodules can be effectively inhibited. Toxic and side effects and adverse reactions are avoided.

This invention provides a lung stem cell peptide for treating pulmonary nodules, its preparation method, and its application, belonging to the field of biopharmaceutical technology. The invention involves inducing iPSCs to differentiate into lung stem cells; culturing the lung stem cells, centrifuging, collecting the supernatant to obtain crude lung stem cell solution; mixing the crude lung stem cell solution with a protease for enzymatic hydrolysis, centrifuging, concentrating, and spray-drying to obtain the lung stem cell peptide for treating pulmonary nodules. This invention optimizes the composition of each culture medium to induce iPSCs to differentiate into lung stem cells, then extracts and separates lung stem cell peptides from these cells. The extracted lung stem cell peptides are intravenously reinfused into the lungs, effectively inhibiting the formation of pulmonary tumor nodules, significantly reducing the number of pulmonary tumor nodules, and without toxic side effects or adverse reactions.